Needles, pens and pressure: The GLP-1 challenge Kalyani Sharma Nov 5, 2025 The rapid global adoption of GLP-1 based therapies, developed for diabetes and now also used for weight management, has reshaped…
Will India pass the cough syrup trust test this time? Viveka Roychowdhury Nov 3, 2025 While India’s CDMOs are well positioned to capitalise on the booming GLP-1 market, the recurring episodes of contaminated cough…
OneSource pharma launches new brand identity at CPHI, Milan EP News Bureau Oct 8, 2024 OneSource Pharma targets biologics and drug-device markets with end-to-end solutions and global expansion
Obesity drug tirzepatide approval in China strengthens market position amid GLP-1 agonist… GlobalData Aug 9, 2024 Benemae’s benaglutide injection (Feisumei) was the first innovator approved for obesity in July 2023 in China followed by Novo…